title: Undetectable CSF hypocretin-1 in "Hashimoto's encephalopathy" associated with coma.
authors.affiliation: Sleep Disorders Center, Mayo Clinic, Jacksonville, FL 55905, USA.
authors.forename: Pablo R
authors.initials: PR
authors.lastname: Castillo
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Mignot
authors.forename: Bryan K
authors.initials: BK
authors.lastname: Woodruff
authors.forename: Bradley F
authors.initials: BF
authors.lastname: Boeve
mesh_terms: D000368:Aged; D020274:Autoimmune Diseases of the Nervous System / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000209:etiology*; D001927:Brain Diseases / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000209:etiology*; D002352:Carrier Proteins / Q000134:cerebrospinal fluid*; D003128:Coma / Q000134:cerebrospinal fluid* / Q000209:etiology; D006970:Disorders of Excessive Somnolence / Q000134:cerebrospinal fluid* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D000068797:Orexins; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D013967:Thyroiditis, Autoimmune / Q000150:complications*
chemical_list: D002352:Carrier Proteins; C000596229:HCRT protein, human; D007166:Immunosuppressive Agents; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D011241:Prednisone; D008775:Methylprednisolone